4//SEC Filing
CAUSEY CHRISTOPHER 4
Accession 0001237334-25-000003
CIK 0001082554other
Filed
Sep 1, 8:00 PM ET
Accepted
Sep 2, 4:39 PM ET
Size
11.6 KB
Accession
0001237334-25-000003
Insider Transaction Report
Form 4
CAUSEY CHRISTOPHER
Director
Transactions
- Exercise/Conversion
Common Stock
2025-09-02$132.30/sh+3,000$396,900→ 7,865 total - Sale
Common Stock
2025-09-02$419.63/sh−1,000$419,630→ 6,865 total - Sale
Common Stock
2025-09-02$430.00/sh−1,000$430,000→ 5,865 total - Sale
Common Stock
2025-09-02$420.00/sh−1,000$420,000→ 4,865 total - Exercise/Conversion
Stock Option
2025-09-02−3,000→ 0 totalExercise: $132.30From: 2018-06-28Exp: 2027-06-28→ Common Stock (3,000 underlying)
Footnotes (1)
- [F1]This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on December 24, 2024.
Documents
Issuer
UNITED THERAPEUTICS Corp
CIK 0001082554
Entity typeother
Related Parties
1- filerCIK 0001237334
Filing Metadata
- Form type
- 4
- Filed
- Sep 1, 8:00 PM ET
- Accepted
- Sep 2, 4:39 PM ET
- Size
- 11.6 KB